Linda M. Richardson

Insider Reports History

Location
Durham, NC
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Linda M. Richardson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Altimmune, Inc. Chief Commercial Officer Stock Options (option to buy) 278,000 16 Sep 2025 Direct
Altimmune, Inc. Chief Commercial Officer Restricted Stock Units 96,000 16 Sep 2025 Direct
INTERCEPT PHARMACEUTICALS, INC. EVP & Chief Commercial Officer Common Stock 0 $19.00 08 Nov 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. EVP & Chief Commercial Officer Option to Purchase Common Stock 0 08 Nov 2023 Direct

Insider Reports Filed by Linda M. Richardson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALT Altimmune, Inc. 16 Sep 2025 2 $0 4 Chief Commercial Officer 17 Sep 2025, 16:38
ALT Altimmune, Inc. 16 Sep 2025 0 $0 3 Chief Commercial Officer 17 Sep 2025, 16:36
/report/000110465923117112-richardson-linda-m-2023-11-08 INTERCEPT PHARMACEUTICALS, INC. 08 Nov 2023 10 -$822,529 4 EVP & Chief Commercial Officer 13 Nov 2023, 14:46
/report/000110465923022788-richardson-linda-m-2023-02-14 INTERCEPT PHARMACEUTICALS, INC. 14 Feb 2023 1 -$8,187 4 EVP & Chief Commercial Officer 16 Feb 2023, 15:01
/report/000110465923008586-richardson-linda-m-2023-01-27 INTERCEPT PHARMACEUTICALS, INC. 27 Jan 2023 2 $0 4 EVP & Chief Commercial Officer 31 Jan 2023, 15:05
/report/000110465923000335-richardson-linda-m-2022-12-31 INTERCEPT PHARMACEUTICALS, INC. 31 Dec 2022 1 -$19,792 4 EVP & Chief Commercial Officer 03 Jan 2023, 15:02
/report/000110465922097842-richardson-linda-m-2022-09-01 INTERCEPT PHARMACEUTICALS, INC. 01 Sep 2022 1 -$10,782 4 EVP & Chief Commercial Officer 06 Sep 2022, 16:01
/report/000110465922092171-richardson-linda-m-2022-08-15 INTERCEPT PHARMACEUTICALS, INC. 15 Aug 2022 1 -$2,256 4 EVP & Chief Commercial Officer 17 Aug 2022, 16:01
/report/000110465922061928-richardson-linda-m-2022-05-15 INTERCEPT PHARMACEUTICALS, INC. 15 May 2022 1 -$2,217 4 EVP & Chief Commercial Officer 17 May 2022, 16:01
/report/000110465922024720-richardson-linda-m-2022-02-15 INTERCEPT PHARMACEUTICALS, INC. 15 Feb 2022 1 -$2,724 4 EVP & Chief Commercial Officer 17 Feb 2022, 15:01
/report/000110465922023839-richardson-linda-m-2022-02-14 INTERCEPT PHARMACEUTICALS, INC. 14 Feb 2022 1 -$7,856 4 EVP & Chief Commercial Officer 15 Feb 2022, 15:48
/report/000110465922009562-richardson-linda-m-2022-01-27 INTERCEPT PHARMACEUTICALS, INC. 27 Jan 2022 2 $0 4 EVP & Chief Commercial Officer 31 Jan 2022, 15:15
/report/000110465922000933-richardson-linda-m-2021-12-31 INTERCEPT PHARMACEUTICALS, INC. 31 Dec 2021 1 -$19,727 4 EVP & Chief Commercial Officer 04 Jan 2022, 15:19
/report/000110465921140302-richardson-linda-m-2021-11-15 INTERCEPT PHARMACEUTICALS, INC. 15 Nov 2021 1 -$3,022 4 EVP & Chief Commercial Officer 17 Nov 2021, 06:00
/report/000110465921113043-richardson-linda-m-2021-09-01 INTERCEPT PHARMACEUTICALS, INC. 01 Sep 2021 1 -$12,341 4 EVP & Chief Commercial Officer 03 Sep 2021, 19:01
/report/000110465921106547-richardson-linda-m-2021-08-15 INTERCEPT PHARMACEUTICALS, INC. 15 Aug 2021 1 -$2,551 4 EVP & Chief Commercial Officer 16 Aug 2021, 19:00
/report/000110465921068371-richardson-linda-m-2021-05-15 INTERCEPT PHARMACEUTICALS, INC. 15 May 2021 1 -$3,104 4 EVP & Chief Commercial Officer 17 May 2021, 19:00